The study findings showed increased risks of dementia for anticholinergic drugs overall and specifically for the ...
The funding comes from a county program that offers cash to businesses that want to expand locally and add at least 10 new ...
BIIB122, previously known as DNL151, is a small molecule designed to inhibit LRRK2, mutations in which are the most common cause of inherited Parkinson's.
The new Marie Skłodowska-Curie Doctoral Network AIPD is dedicated to investigating artificial intelligence methods to combat Parkinson's disease. It ...
Parkinson's disease is the second most common neurodegenerative disorder, and case numbers are growing quickly. The disease presents a great challenge for people living with it, caregivers, relatives, ...
After his Parkinson's diagnosis, Jimmy Choi had a cane and extra weight. Things changed when he started to exercise; he now ...
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
The Phase 2a study is intended to evaluate safety and biomarkers associated with oral daily dosing of BIIB122 in approximately 50 participants with Parkinson’s disease and LRRK2 pathogenic mutations ...
Although there is no cure, there are ways to relieve the tremors, stiffness, depression, anxiety, and memory problems caused ...
Construction workers and others look on as crews install the final beam for the $838 million, 500,000 square foot, ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.